Research Article
Prognostic Value of Concurrent Expression of C-MYC and BCL2 in Intravascular Large B-Cell Lymphoma: A 10-Year Retrospective Study
Table 4
Association between histochemical expression and incidence rate to complete remission and mortality.
| Characteristics | "Complete remission rate" (persons per 100 persons per month) | value | "Mortality rate" (persons per 100 persons per month) | value | Positive | Negative | Positive | Negative |
| Non-GCB-like variant | 8.0 | 14.4 | 0.429 | 4.5 | 0.0 | 0.356 | C-MYC/BCL2 double expressor | 3.7 | 11.8 | 0.212 | 14.0 | 1.8 | 0.042 | CD5+ | 8.9 | 9.6 | 0.892 | 4.8 | 4.2 | 0.985 | CD30+ | 0.0 | 9.2 | 1.000 | 57.5 | 3.7 | 0.086 | C-MYC+ | 3.7 | 11.8 | 0.213 | 14.0 | 1.8 | 0.042 | P53+ | 9.4 | 8.3 | 0.549 | 4.4 | 4.3 | 0.901 |
|
|
Statistical significance. All patients with positive C-MYC showed positive result for BCL2. |